Advanced endometrial clear cell carcinoma (CCC) tends to have poor prognosis owing to aggressive clinical behavior and poor response to conventional chemotherapy. Herein, we report a case of platinum-refractory recurrent ECCC successfully treated with the combination of pembrolizumab, localized radiotherapy and a few cycles of chemotherapy with an extremely durable response even after cessation of immunotherapy for 3 years at the time of publication.
CITATION STYLE
Kao, C. H., Liu, C. T., Lin, H., Huang, Y. C., Lan, J., Ou, Y. C., … Wu, C. H. (2022). Case report: Durable response after pembrolizumab in combination with radiation - induced abscopal effect in platinum - refractory metastatic endometrial clear cell carcinoma. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.1079253
Mendeley helps you to discover research relevant for your work.